We’ve launched a new website!
Click “Sign Up Today” to create a new account, (previous usernames and passwords will no longer work)
to access your profile, manage prescriptions, and enjoy an improved experience.
We also have a NEW mobile app coming soon!

Get Healthy!

  • Posted December 16, 2025

Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?

In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”

Health News is provided as a service to Corner & Victor Drug site users by HealthDay. Corner & Victor Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.